← Back to Search

Intracardiac Echocardiography for Hypertrophic Cardiomyopathy

N/A

Waitlist Available

Led By Daniel Swistel, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Those hypertrophic cardiomyopathy patients who are scheduled to receive a septal myectomy who are less than 18 years old or whose preoperative transthoracic echocardiograph suggests an interventricular septal width of greater than 2.0 cm.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the conclusion of all data collection; approximately 6 to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is investigating whether or not a new intraoperative echocardiography technique called OPIE is as effective as traditional methods in measuring the thickness of the left ventricular septum in patients with hypertrophic cardiomyopathy.

Who is the study for?

This trial is for adults over 18 with hypertrophic cardiomyopathy scheduled for septal myectomy and have a thin interventricular septum (less than 2.0 cm wide) as shown by echocardiography. It's open to all genders and races.

What is being tested?

The study tests on-pump intracardiac echocardiography (OPIE) against traditional transthoracic and transesophageal methods in measuring ventricular septal thickness during surgery for those with a thin septum.

What are the potential side effects?

There are no direct side effects from the OPIE procedure itself, as it involves additional imaging during an already-planned surgery, adding less than five minutes to the operation.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 and scheduled for heart surgery due to thickened heart muscle.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the conclusion of all data collection; approximately 6 to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the conclusion of all data collection; approximately 6 to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the conclusion of all data collection; approximately 6 to 12 months for reporting.